Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
60
AFJK Quote, Financials, Valuation and Earnings
Last price:
$36.12
Seasonality move
:
1.54%
Day range:
$36.03 - $51.50
52-week range:
$6.75 - $98.15
Dividend yield:
0%
P/E ratio:
178.81x
P/S ratio:
--
P/B ratio:
5.25x
Volume:
125.4K
Avg. volume:
318.2K
1-year change:
239.74%
Market cap:
$220.6M
Revenue:
--
EPS (TTM):
$0.20
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Aimei Health Technology Co., Ltd. has -- downside to fair value with a price target of -- per share.
AFJK vs. S&P 500
-
Over the past 5 trading days, Aimei Health Technology Co., Ltd. has overperformed the S&P 500 by 21.31% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Aimei Health Technology Co., Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Aimei Health Technology Co., Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Aimei Health Technology Co., Ltd. reported revenues of --.
Earnings Growth
-
Aimei Health Technology Co., Ltd. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Aimei Health Technology Co., Ltd. reported earnings per share of $0.06.
Enterprise value:
222.2M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
1.40x
EV / Free cash flow:
-309.93x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
2.51%
Net Income Margin (TTM):
--
Return On Equity:
2.61%
Return On Invested Capital:
2.58%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -$687.6K | -$987.2K | -$200K | -$130.2K | |
| EBITDA | -- | -$687.6K | -$987.2K | -$200K | -$130.1K | |
| Diluted EPS | -$0.00 | $0.25 | $0.20 | $0.08 | $0.06 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $10K | $123.9K | $24.9K | |
| Total Assets | -- | -- | $234.9K | $72.8M | $45.5M | |
| Current Liabilities | -- | -- | $213.6K | $230.8K | $2.8M | |
| Total Liabilities | -- | -- | $213.6K | $920.8K | $3.5M | |
| Total Equity | -- | -- | $21.4K | $71.9M | $42M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$473.5K | -$717K | -$53.9K | -$96.1K | |
| Cash From Investing | -- | -$69.7M | $29.6M | -- | -$450K | |
| Cash From Financing | -- | $70.3M | -$29M | -- | $547K | |
| Free Cash Flow | -- | -$473.5K | -$717K | -$53.9K | -$96.1K | |
AFJK
Sector
Market Cap
$220.6M
--
Price % of 52-Week High
36.71%
--
Dividend Yield
0%
--
Shareholder Yield
44.64%
--
1-Year Price Total Return
239.74%
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$34.00
200-day SMA
Buy
Level
$12.45
Bollinger Bands (100)
Buy
Level
3.78 - 23.88
Chaikin Money Flow
Buy
Level
3.2M
20-day SMA
Buy
Level
$23.23
Relative Strength Index (RSI14)
Buy
Level
54.86
ADX Line
Buy
Level
61.31
Williams %R
Neutral
Level
-67.965
50-day SMA
Buy
Level
$16.38
MACD (12, 26)
Buy
Level
6.93
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Neutral
Level
11.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (38.3634)
Buy
CA Score
(Annual)
Level (1.6925)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-2.7879)
--
Piotroski F Score
(Annual)
Level (--)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.
Stock Forecast FAQ
In the current month, AFJK has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AFJK average analyst price target in the past 3 months is --.
-
Where Will Aimei Health Technology Co., Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Aimei Health Technology Co., Ltd. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Aimei Health Technology Co., Ltd.?
Analysts are divided on their view about Aimei Health Technology Co., Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Aimei Health Technology Co., Ltd. is a Sell and believe this share price will rise from its current level to --.
-
What Is Aimei Health Technology Co., Ltd.'s Price Target?
The price target for Aimei Health Technology Co., Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AFJK A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Aimei Health Technology Co., Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of AFJK?
You can purchase shares of Aimei Health Technology Co., Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Aimei Health Technology Co., Ltd. shares.
-
What Is The Aimei Health Technology Co., Ltd. Share Price Today?
Aimei Health Technology Co., Ltd. was last trading at $36.12 per share. This represents the most recent stock quote for Aimei Health Technology Co., Ltd.. Yesterday, Aimei Health Technology Co., Ltd. closed at $36.03 per share.
-
How To Buy Aimei Health Technology Co., Ltd. Stock Online?
In order to purchase Aimei Health Technology Co., Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get AFJK Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AFJK
Sector
P/E ratio
178.81x
--
PEG ratio
1.40x
--
P/B ratio
5.25x
--
Price / LTM sales
--
--
Growth Metrics
AFJK
Sector
Revenue growth
--
--
Earnings growth
-30.22%
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
AFJK
Sector
Profitability FY 2024
--
--
Return on invested capital
2.58%
--
Return on assets
2.51%
--
Return on equity
2.61%
--
Earnings Date
Last Earnings Date
Dec
21
Next Earnings Date
Dec
21
Estimated Next Earnings Date
Mar
22
Balance Sheet
AFJK
Sector
Total cash
$3K
--
Short term investments
--
--
Total assets
$73.8M
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
